Daniela Hernandez

Episode 38

The Science Behind Controversial New Weight Loss Drugs Like Ozempic

Ozempic, Wegovy, Mounjaro—drugs developed to treat diabetes—are being used for cosmetic weight loss

By Daniela Hernandez

Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez explains how they work, their side effects, and concerns over unintended consequences. Illustration: Elizabeth Smelov

Daniela Hernandez

Daniela Hernandez extends her health and science reporting to cover a variety of relevant subjects from Covid-19 to climate change.

Up Next in Daniela Hernandez

  • E41

    Metformin and Autophagy: The Cellular Recycling Process Behind Aging

    Metformin may have anti-aging properties because of a cellular recycling process called autophagy. WSJ’s Daniela Hernandez explains what autophagy is and why boosting this process might slow aging. Illustration: Elizabeth Smelov
  • E37

    Why Fungi Are the Next Big Global Health Threat

    As certain fungi like Candida auris become more widespread throughout the U.S., deaths related to severe fungal infections are rising. WSJ’s Daniela Hernandez explains what you should know. Composite: Noah Friedman
  • E36

    Inflation Brain: Why You Seesaw Between Splurging and Penny-Pinching

    Amid high inflation, people are splurging more than ever on luxury items while still penny-pinching on other goods and services like groceries. WSJ's Daniela Hernandez explains why. Photo Composite: David Fang